FDA notifications. New tipranavir solution approved.
D000284:Administration, Oral; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use*; D011753:Pyrones / Q000008:administration & dosage / Q000627:therapeutic use*; D012996:Solutions; D013449:Sulfonamides; D014481:United States; D014486:United States Food and Drug Administration
D011725:Pyridines; D011753:Pyrones; D012996:Solutions; D013449:Sulfonamides; C107201:tipranavir